Cargando…

A combination of circulating tumor cells and CA199 improves the diagnosis of pancreatic cancer

BACKGROUND: Early diagnosis of pancreatic ductal adenocarcinoma (PDAC) is difficult due to the lack of effective screening tests. CA199, the standard biomarker for PDAC management, is not sufficiently reliable for early diagnosis. This prospective study aimed to evaluate whether circulating tumor ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Junliang, Wang, Huaitao, Zhou, Lei, Liu, Zhihao, Tan, Xiaodong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102772/ https://www.ncbi.nlm.nih.gov/pubmed/35334495 http://dx.doi.org/10.1002/jcla.24341

Ejemplares similares

A necroptosis‐related gene signature for predicting prognosis, immune landscape, and drug sensitivity in hepatocellular carcinoma
por: Chen, Junliang, et al.
Publicado: (2022)

Diagnostic and Prognostic Impact of Circulating YKL-40, IL-6, and CA 19.9 in Patients with Pancreatic Cancer
por: Schultz, Nicolai A., et al.
Publicado: (2013)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

The prognostic and predictive value of serum CA19.9 in pancreatic cancer
por: Humphris, J. L., et al.
Publicado: (2012)

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
por: Makawita, Shalini, et al.
Publicado: (2013)

Clinical Significance of Color Ultrasound, MRI, miR-21, and CA199 in the Diagnosis of Pancreatic Cancer
por: Yu, Jing, et al.
Publicado: (2021)

Serum CA125, CA199 and CEA Combined Detection for Epithelial Ovarian Cancer Diagnosis: A Meta-analysis
por: Guo, Junhong, et al.
Publicado: (2017)

Periostin and CA242 as potential diagnostic serum biomarkers complementing CA19.9 in detecting pancreatic cancer
por: Dong, Dong, et al.
Publicado: (2018)

Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer
por: Teng, Dongling, et al.
Publicado: (2018)

Diagnostic value of combining preoperative inflammatory markers ratios with CA199 for patients with early-stage pancreatic cancer
por: Gu, Yuanlong, et al.
Publicado: (2023)

The Clinical Value of the Combined Detection of Enhanced CT, MRI, CEA, and CA199 in the Diagnosis of Rectal Cancer
por: Hao, Cuijuan, et al.
Publicado: (2021)

Comparison of diagnostic values between CA125 combined with CA199 and ultrasound combined with CT in ovarian cancer
por: Guo, Bingcheng, et al.
Publicado: (2019)

The Diagnostic Value of Contrast-Enhanced Ultrasound and Enhanced CT Combined with Tumor Markers AFP and CA199 in Liver Cancer
por: Kong, Yunpeng, et al.
Publicado: (2022)

Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients
por: Xu, Wei-Yu, et al.
Publicado: (2018)

UCA1 Regulates the Growth and Metastasis of Pancreatic Cancer by Sponging miR-135a
por: Zhang, Xiaobo, et al.
Publicado: (2017)

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer
por: Jahan, Rahat, et al.
Publicado: (2019)

Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives
por: Coppola, Alessandro, et al.
Publicado: (2022)

The additive value of CA19.9 monitoring in a pancreatic cyst surveillance program
por: Levink, Iris J. M., et al.
Publicado: (2023)

Sensitivity and specificity of microRNA-204, CA125, and CA19.9 as biomarkers for diagnosis of ovarian cancer
por: Ali, Fahmy T., et al.
Publicado: (2022)

Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer
por: Chen, Hui, et al.
Publicado: (2022)

Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?
por: Woei-A-Jin, F J Sherida H, et al.
Publicado: (2016)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
por: Chen, Junliang, et al.
Publicado: (2023)

The role of circulating miRNAs and CA19-9 in pancreatic cancer diagnosis
por: Vieira, Nivaldo Faria, et al.
Publicado: (2021)

Potential of combination of DCE-MRI and DWI with serum CA125 and CA199 in evaluating effectiveness of neoadjuvant chemotherapy in breast cancer
por: Zhang, Jun, et al.
Publicado: (2021)

A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma
por: Zheng, Bo-Hao, et al.
Publicado: (2017)

Phosphoproteome Analysis of Invasion and Metastasis-Related Factors in Pancreatic Cancer Cells
por: Tan, Xiaodong, et al.
Publicado: (2016)

Value of biplane transrectal ultrasonography plus micro-flow imaging in preoperative T staging and rectal cancer diagnosis in combination with CEA/CA199 and MRI
por: Xia, Qin, et al.
Publicado: (2023)

Clinical Significance of CYFRA21-1, AFP, CA-153, CEA, and CA-199 in the Diagnosis of Lung Cancer Ocular Metastasis in Hypertension Population
por: Tang, Jing, et al.
Publicado: (2021)

TSPAN1 upregulates MMP2 to promote pancreatic cancer cell migration and invasion via PLCγ
por: Zhang, Xiaobo, et al.
Publicado: (2019)

Predictive value of CONUT score combined with serum CA199 levels in postoperative survival of patients with pancreatic ductal adenocarcinoma: a retrospective study
por: Wang, Ankang, et al.
Publicado: (2020)

MicroRNA-199a and -214 as potential therapeutic targets in pancreatic stellate cells in pancreatic tumor
por: Kuninty, Praneeth R., et al.
Publicado: (2016)

Integrated analysis identifies a pathway-related competing endogenous RNA network in the progression of pancreatic cancer
por: Zu, Fuqiang, et al.
Publicado: (2020)

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer
por: Chen, Hui, et al.
Publicado: (2023)

CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
por: Maggino, Laura, et al.
Publicado: (2022)

Gastrin-17 Combined with CEA, CA12-5 and CA19-9 Improves the Sensitivity for the Diagnosis of Gastric Cancer
por: Wang, Zhen, et al.
Publicado: (2021)

Circulating Tumor Cells and Circulating Tumor DNA Provide New Insights into Pancreatic Cancer
por: Gao, Yang, et al.
Publicado: (2016)

Combined detection of aneuploid circulating tumor‐derived endothelial cells and circulating tumor cells may improve diagnosis of early stage non‐small‐cell lung cancer
por: Lei, Yuanyuan, et al.
Publicado: (2020)

Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.
por: Kawa, S., et al.
Publicado: (1994)

Evaluation of serum MUC5AC in combination with CA19-9 for the diagnosis of pancreatic cancer
por: Zhang, Jiayu, et al.
Publicado: (2020)

Applying circulating tumor DNA methylation in the diagnosis of lung cancer
por: Li, Lei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bn0uio9vlhd0hnm4rktpoqaqc3